Compare iShares MSCI France ETF (EWQ) vs Moderna, Inc. (MRNA) Price & Performance

iShares MSCI France ETFTrade

Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

iShares MSCI France ETF vs Moderna, Inc. — how do they compare? iShares MSCI France ETF trades at $45.13, while Moderna, Inc. trades at $65.36 (market cap $27.09B). The key difference: Moderna, Inc. is trading nearer its 52-week high, iShares MSCI France ETF nearer its low. Which is the better fit depends on your goals.

	EWQ	MRNA
Sector	Broad Market / Factor	Health
52-Week High	$48.35	$81.80
52-Week Low	$41.43	$22.36
Market Cap	—	$27.09B
Enterprise Value	—	$23.19B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI France ETF

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $67.44, showing modest daily gains amid a bullish technical signal. The company continues to beat earnings expectations despite reporting significant net losses, with revenue declining from pandemic peaks to $1.92B in 2025. Recent positive developments include EU RSV vaccine contracts, Phase 1 cancer trial initiation, and FDA advisory panel support for its mRNA flu vaccine, driving recent stock momentum.

While Moderna's pipeline expansion beyond COVID-19 shows promise with oncology and rare disease applications, substantial financial risks persist with negative profit margins and cash burn. Analyst consensus remains cautious with a $49 price target below current levels, reflecting concerns about revenue sustainability versus pipeline execution risks and valuation metrics.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

EWQ

Spain's single-nation ETF leads World Cup finalists with 37.6% return, outperforming France, UK, and Argentina ETFs.ETF Trends · 3 days agoNeutral View details →

MRNA

Arbutus sues Pfizer/BioNTech over LNP patents, gets $178M from Moderna, plans $230M share buybackGlobeNewsWire · 7 hours agoNeutral Moderna's Q2 report expected uneventful; key focus on COVID vaccine demand and Phase III melanoma data.Proactive Investors · 2 days agoNeutral View details →

About iShares MSCI France ETF

EWQ is a country-specific ETF that tracks the performance of the French equity market. It provides exposure to major global brands across sectors like luxury goods, industrials, and healthcare, including LVMH, Schneider Electric, and Hermes.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.